Cambrex

We’re proud to highlight what makes Cambrex a unique CDMO: a relentless passion for scientific problem-solving and a mission-driven approach to drug development. Through collaboration and our global support network, we empower clients to reach clinical milestones and bring new therapies to life. With deep expertise and a culture of innovation, we reinforce our promise: your molecule is our mission. Connect with Cambrex: https://lnkd.in/eX94pntt

Sending our congratulations to the teams at NewAmsterdam Pharma Corporation and Snapdragon Chemistry, a Cambrex company, for receiving the American Chemical Society’s 2026 Green Chemistry Challenge Award for the Greener Synthetic Pathway in the Synthesis of Pharmaceuticals. The award recognizes the companies’ successful development of a sustainable organocatalytic process to manufacture the chiral tetrahydroquinoline core for the synthesis of obicetrapib, a late-stage investigational therapy for dyslipidemia. Read the full release here: https://lnkd.in/eVQTdRFE

“Efficient technology transfer can be achieved and improved by systematically gathering more data during the development phase. By using approaches such as design of experiments (DoE), we gain a much improved understanding of the limitations of your process, which significantly helps in successful manufacturing, if that is the next step.” Karlskoga R&D Director Ingrid Ekman relies on robust data – and over 30 years of experience at Cambrex – to optimize tech transfer and deliver manufacturing success. She’s a different brand of expert. So, what brand of expertise do you personify? Let us know in the comments.

“Design of experiments (DoE) approaches and many different tools, including automated reactors equipped with probes that gather relevant process data, allow us to build the models and knowledge that we need with the minimum number of experiments.” Cambrex Milan Assistant Director Daniele Vigo employs the latest science and technology to boost generic API yield and quality. He’s a different brand of expert. So, what brand of expertise do you personify? Let us know in the comments.

“I sincerely believe that process development and scale-up can be accelerated through optimized digitalization. Providing more data to scientists in the same time period allows more justified decisions to be made and enables development of models that predict scale-up factors that will be beneficial during manufacturing.” Cambrex Karlskoga R&D Director Ingrid Ekman embraces Pharma 4.0 approaches to smoothly scale up at speed. She’s a different brand of expert. So, what brand of expertise do you personify? Let us know in the comments.